NCT06918925View on ClinicalTrials.gov

First-In-Human Study to Evaluate Single Ascending Doses of JUV-161 in Healthy Adult Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 14, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Healthy Volunteer
Interventions
DRUG

JUV-161, Placebo

Single-Ascending, Placebo-Controlled

Trial Locations (1)

3004

RECRUITING

Nucleus Network Pty Ltd, Melbourne

Sponsors
All Listed Sponsors
lead

Juvena Therapeutics

INDUSTRY

NCT06918925 - First-In-Human Study to Evaluate Single Ascending Doses of JUV-161 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter